Additionally it is authorized for adults who will be overweight with one or more weight-linked situations, such as significant blood pressure or Form 2 diabetic issues (higher blood sugar). In March of 2024, the FDA permitted an extra indicator for Wegovy—to reduced the potential risk of cardiovascular Loss of life, https://glp-1weightlossmed.com/product/wegovy/